Yifan Xinfu Pharmaceutical Co Ltd Financial Flexibility Index
Yifan Xinfu Pharmaceutical Co Ltd financial flexibility index. Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥224.86 Million (operating CF CN¥40.18 Million minus capex CN¥184.68 Million) represents 0% of total liabilities (CN¥4.40 Billion). See 002019 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Financial flexibility index of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. Historical Financial Flexibility Index trend for Yifan Xinfu Pharmaceutical Co Ltd across 23 annual periods. Check 002019 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Yifan Xinfu Pharmaceutical Co Ltd Financial Flexibility Index by Year (2003–2025)
Yifan Xinfu Pharmaceutical Co Ltd financial flexibility index by year from 2003 to 2025. Year-by-year free cash flow to debt coverage for Yifan Xinfu Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Yifan Xinfu Pharmaceutical Co Ltd (002019) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥1.02 Billion | CN¥458.37 Million | CN¥4.13 Billion | ▼ -25.1% |
| 2024 | 0.33x | CN¥1.27 Billion | CN¥640.73 Million | CN¥3.86 Billion | ▲ +25.1% |
| 2023 | 0.26x | CN¥852.67 Million | CN¥348.58 Million | CN¥3.24 Billion | ▼ -12.0% |
| 2022 | 0.30x | CN¥1.01 Billion | CN¥472.07 Million | CN¥3.40 Billion | ▲ +16.0% |
| 2021 | 0.26x | CN¥872.97 Million | CN¥301.23 Million | CN¥3.39 Billion | ▼ -57.8% |
| 2020 | 0.61x | CN¥1.82 Billion | CN¥1.11 Billion | CN¥2.99 Billion | ▲ +9.8% |
| 2019 | 0.56x | CN¥1.80 Billion | CN¥937.24 Million | CN¥3.24 Billion | ▼ -15.5% |
| 2018 | 0.66x | CN¥1.90 Billion | CN¥1.17 Billion | CN¥2.89 Billion | ▼ -19.3% |
| 2017 | 0.82x | CN¥1.62 Billion | CN¥1.13 Billion | CN¥1.99 Billion | ▲ +119.8% |
| 2016 | 0.37x | CN¥1.14 Billion | CN¥855.85 Million | CN¥3.08 Billion | ▼ -0.2% |
| 2015 | 0.37x | CN¥619.11 Million | CN¥401.96 Million | CN¥1.67 Billion | ▲ +28.2% |
| 2014 | 0.29x | CN¥229.24 Million | CN¥139.74 Million | CN¥791.21 Million | ▼ -22.9% |
| 2013 | 0.38x | CN¥108.27 Million | CN¥34.32 Million | CN¥288.20 Million | ▲ +123.7% |
| 2012 | 0.17x | CN¥97.52 Million | CN¥29.88 Million | CN¥580.73 Million | ▲ +149.4% |
| 2011 | 0.07x | CN¥46.92 Million | CN¥-52.82 Million | CN¥696.73 Million | ▼ -79.7% |
| 2010 | 0.33x | CN¥165.50 Million | CN¥-33.82 Million | CN¥497.79 Million | ▼ -64.0% |
| 2009 | 0.92x | CN¥209.88 Million | CN¥58.61 Million | CN¥227.31 Million | ▲ +28.1% |
| 2008 | 0.72x | CN¥205.76 Million | CN¥83.31 Million | CN¥285.39 Million | ▼ -42.4% |
| 2007 | 1.25x | CN¥420.77 Million | CN¥248.71 Million | CN¥335.87 Million | ▲ +271.9% |
| 2006 | 0.34x | CN¥90.24 Million | CN¥32.62 Million | CN¥267.92 Million | ▼ -20.2% |
| 2005 | 0.42x | CN¥82.76 Million | CN¥24.12 Million | CN¥196.02 Million | ▼ -80.2% |
| 2004 | 2.13x | CN¥103.73 Million | CN¥33.59 Million | CN¥48.72 Million | ▲ +242.5% |
| 2003 | 0.62x | CN¥65.09 Million | CN¥12.65 Million | CN¥104.73 Million | — |